Related Experiment Video

Updated: Jul 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Congestive heart failure and diabetes mellitus: an intricated relationship]

J De Flines1, A J Scheen

  • 1Service de Diabétologie, Nutrition et Maladies métaboliques et de Médecine interne générale, Département de Médecine, CHU Sart Tilman, Liège, Belgique.

Revue Medicale De Liege
|April 28, 2007
PubMed

Insights

Diabetes mellitus and congestive heart failure share a bidirectional relationship. Diabetes increases heart failure risk, while heart failure can lead to new-onset diabetes, influenced by medications like glitazones.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Context:

  • The intricate relationship between diabetes mellitus and congestive heart failure (CHF) is increasingly recognized.
  • Type 2 diabetes is a significant risk factor for CHF, involving complex mechanisms beyond traditional cardiovascular risk factors.
  • CHF is also associated with an elevated risk of developing type 2 diabetes.

Purpose:

  • To analyze the bidirectional relationship between diabetes mellitus and congestive heart failure.
  • To explore the underlying pathophysiological mechanisms contributing to this association.
  • To discuss the implications of specific diabetes medications, such as thiazolidinediones (glitazones), on CHF in diabetic patients.

Summary:

  • Diabetes mellitus, particularly type 2, predisposes individuals to CHF through a combination of risk factors and diabetic cardiomyopathy.
  • CHF can increase the risk of new-onset type 2 diabetes, potentially mediated by reduced muscular perfusion and neurohumoral responses.
  • While glitazones may offer cardiovascular protection, they are linked to fluid retention, which can precipitate or worsen CHF in diabetic patients.

Impact:

  • Understanding this bidirectional link is crucial for managing both conditions effectively.
  • This review highlights the need for careful monitoring of cardiovascular status in diabetic patients and vice versa.
  • The findings underscore the importance of considering medication side effects, such as fluid retention from glitazones, in the context of CHF risk.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...